• Oligo (dT) 25 Beads: Protocols for Eukaryotic mRNA Isolation

  2026-07-06

  Oligo (dT) 25 Beads (SKU K1306) are designed for efficient eukaryotic mRNA isolation from total RNA or cell/tissue lysates, enabling downstream applications such as cDNA synthesis and RT-PCR. They are not recommended for prokaryotic samples or workflows requiring non-polyadenylated RNA capture. Proper handling and protocol adherence are critical for reproducibility and RNA integrity.

• LY2886721 (SKU A8465): Reproducible BACE1 Inhibition in the

  2026-07-06

  This article delivers scenario-driven guidance for biomedical researchers using LY2886721 (SKU A8465), a potent oral BACE1 inhibitor, in cell viability and amyloid beta reduction workflows. Drawing on evidence-based practice and recent literature, we address experimental design, protocol optimization, data interpretation, and reliable vendor selection—highlighting how LY2886721 from APExBIO enables sensitive, reproducible Alzheimer’s disease research.

• Antidepressant Properties of Rotigotine in Preclinical Model

  2026-07-05

  This study systematically evaluated rotigotine, a dopamine D2/D3 receptor agonist, for its antidepressant effects in validated rodent models. The research demonstrates that rotigotine exerts antidepressant-like activity at specific dose ranges, offering mechanistic and translational value for Parkinson’s disease research and comorbid depression.

• Hydrocortisone in Inflammation Model Research: Advanced Work

  2026-07-04

  Hydrocortisone stands out as a benchmark glucocorticoid hormone for dissecting inflammation models and stress response mechanisms. This article translates latest research and workflow refinements into actionable protocols, with troubleshooting tips and cross-study insights for maximum reproducibility.

• Sequential Dual-Targeting Liposomes Remodel Tumor Immunity

  2026-07-03

  This study presents an MMP-2 responsive liposomal system for sequentially delivering a PD-1/PD-L1 blockade peptide and an IDO inhibitor, addressing major hurdles in breast cancer immunotherapy. The intelligent design enhances immune activation while minimizing toxicity, representing a significant advance in tumor-targeted drug delivery.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflow

  2026-07-03

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for reliable, sensitive detection of goat-derived primary antibodies in fluorescence-based immunodetection workflows. It is intended for use in ICC/IF, IHC, flow cytometry, and ELISA, but is not suitable for non-goat primaries or non-immunodetection applications. Integration with validated workflows and careful storage are required for optimal performance.

• Faropenem Sodium: Advanced Penem Antibiotic Workflows in Res

  2026-07-02

  Faropenem sodium stands out for its unique transporter-mediated renal elimination, β-lactamase stability, and superior activity against Gram-positive, Gram-negative, and anaerobic bacteria. This guide delivers actionable protocols, troubleshooting insights, and comparative advantages for researchers seeking robust, reproducible results in antimicrobial and resistance studies.

• Tropisetron Hydrochloride: Reliable Solutions for Cell Viabi

  2026-07-02

  This in-depth guide addresses common challenges in cell viability and receptor signaling workflows, highlighting how Tropisetron Hydrochloride (SKU B2258) delivers consistent, literature-backed performance. Drawing from peer-reviewed studies and practical lab scenarios, we demonstrate why APExBIO’s research-grade formulation is a dependable choice for sensitive and reproducible results.

• Trelagliptin succinate (SKU A3889): Data-Driven Lab Solution

  2026-07-01

  This article provides laboratory scientists with scenario-driven guidance for using Trelagliptin succinate (SKU A3889) in cell viability, proliferation, and cytotoxicity assays. With evidence-based answers and cross-comparisons, it demonstrates how SKU A3889 from APExBIO supports reproducible, high-sensitivity workflows and addresses real-world experimental challenges.

• Ivermectin in Anti-Parasitic Research: Protocols and Innovat

  2026-07-01

  Unlock the full potential of Ivermectin as a broad-spectrum anti-parasitic for advanced bench research. This article details actionable protocols, troubleshooting strategies, and cross-domain insights, translating recent breakthroughs in tumor microenvironment studies into practical laboratory workflows.

• GANT61 (SKU A1615): Reliable GLI Inhibition for Cancer Resea

  2026-06-30

  This article addresses common laboratory challenges in GLI-mediated transcription inhibition and tumor growth suppression workflows, integrating scenario-driven solutions with GANT61 (SKU A1615). Drawing on recent literature and validated product data, it guides biomedical researchers through evidence-based experimental design, optimization, and vendor selection for robust cancer research results.

• Y-27632 Dihydrochloride: Selective ROCK Inhibitor in Stem Ce

  2026-06-30

  Y-27632 dihydrochloride is a potent, selective ROCK1/2 inhibitor widely used to study cytoskeletal dynamics, stem cell viability, and tumor invasion. It exhibits high affinity for ROCK1 (IC50 ~140 nM) and ROCK2 (Ki ~300 nM), with over 200-fold selectivity against related kinases. This specificity underpins its utility in dissecting Rho-mediated signaling in cellular and animal models.

• CCR5-Positive Extracellular Vesicles Drive RA Joint Damage

  2026-06-29

  This study reveals that CCR5-containing extracellular vesicles (EVs) from synovial fibroblasts promote cartilage and bone damage in rheumatoid arthritis (RA) by amplifying joint inflammation. Blockade of CCR5, including via encapsulated Maraviroc, attenuates these pathogenic effects, highlighting CCR5 as a promising therapeutic target for RA intervention.

• Hydrocortisone for Advanced Inflammation & EMT Research Work

  2026-06-29

  Hydrocortisone stands as the gold-standard glucocorticoid hormone for dissecting anti-inflammatory pathways, barrier protection, and epithelial-to-mesenchymal transition (EMT) in both basic and translational research. This guide delivers validated protocols, troubleshooting insights, and evidence-driven applications—empowering labs to maximize rigor in inflammation model research, stress response mechanism studies, and metastatic cancer assays.

• HBTU (A7023): Precision Peptide Bond Formation & Benchmarks

  2026-06-28

  HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) is a racemization-resistant coupling reagent widely used in peptide bond formation. It is valued for its mild activation, high yield, and compatibility with solid phase peptide synthesis. This article details its mechanism, evidence base, and integration into advanced peptide therapeutic workflows.

7835 records 15/523 page Previous Next First page 上5页 1112131415 下5页 Last page